BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2566144)

  • 1. Loss of heterozygosity at the c-raf locus in small cell lung carcinoma.
    Sithanandam G; Dean M; Brennscheidt U; Beck T; Gazdar A; Minna JD; Brauch H; Zbar B; Rapp UR
    Oncogene; 1989 Apr; 4(4):451-5. PubMed ID: 2566144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphic sites within the MCC and APC loci reveal very frequent loss of heterozygosity in human small cell lung cancer.
    D'Amico D; Carbone DP; Johnson BE; Meltzer SJ; Minna JD
    Cancer Res; 1992 Apr; 52(7):1996-9. PubMed ID: 1348017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of the RAF1 locus, at band 3p25, in the 3p deletion of small-cell lung cancer.
    Graziano SL; Pfeifer AM; Testa JR; Mark GE; Johnson BE; Hallinan EJ; Pettengill OS; Sorenson GD; Tatum AH; Brauch H
    Genes Chromosomes Cancer; 1991 Jul; 3(4):283-93. PubMed ID: 1683566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of p64c-myc and neuroendocrine properties define three subclasses of small cell lung cancer.
    Bepler G; Bading H; Heimann B; Kiefer P; Havemann K; Moelling K
    Oncogene; 1989 Jan; 4(1):45-50. PubMed ID: 2536917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA restriction fragment length polymorphisms at either end of the c-raf-1 locus at 3p25.
    Graziano SL; Mark GE; Murray C; Mann DL; Ehrlich GD; Poiesz BJ; Weston A
    Oncogene Res; 1988; 3(1):99-103. PubMed ID: 2905034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple genetic alterations in small-cell lung carcinoma.
    Yokota J; Mori N; Akiyama T; Shimosato Y; Sugimura T; Terada M
    Princess Takamatsu Symp; 1989; 20():43-8. PubMed ID: 2577337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer.
    Schneider PM; Hung MC; Chiocca SM; Manning J; Zhao XY; Fang K; Roth JA
    Cancer Res; 1989 Sep; 49(18):4968-71. PubMed ID: 2569928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic lesion in the carcinogenesis of cervical cancer.
    Chung GT; Huang DP; Lo KW; Chan MK; Wong FW
    Anticancer Res; 1992; 12(5):1485-90. PubMed ID: 1359830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetics of small cell lung carcinoma.
    Wistuba II; Gazdar AF; Minna JD
    Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A frequent deletion of chromosome 5q21 in advanced small cell and non-small cell carcinoma of the lung.
    Hosoe S; Ueno K; Shigedo Y; Tachibana I; Osaki T; Kumagai T; Tanio Y; Kawase I; Nakamura Y; Kishimoto T
    Cancer Res; 1994 Apr; 54(7):1787-90. PubMed ID: 7907944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. erbA-related sequence coding for DNA-binding hormone receptor localized to chromosome 3p21-3p25 and deleted in small cell lung carcinoma.
    Dobrovic A; Houle B; Belouchi A; Bradley WE
    Cancer Res; 1988 Feb; 48(3):682-5. PubMed ID: 2891438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion mapping of chromosome 2 in human lung carcinoma.
    Otsuka T; Kohno T; Mori M; Noguchi M; Hirohashi S; Yokota J
    Genes Chromosomes Cancer; 1996 Jun; 16(2):113-9. PubMed ID: 8818658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.
    Ma PC; Kijima T; Maulik G; Fox EA; Sattler M; Griffin JD; Johnson BE; Salgia R
    Cancer Res; 2003 Oct; 63(19):6272-81. PubMed ID: 14559814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concordant deletions of chromosome 3p and loss of heterozygosity for chromosomes 13 and 17 in small cell lung carcinoma.
    Mori N; Yokota J; Oshimura M; Cavenee WK; Mizoguchi H; Noguchi M; Shimosato Y; Sugimura T; Terada M
    Cancer Res; 1989 Sep; 49(18):5130-5. PubMed ID: 2569931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
    Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
    Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression in lung cancer of a transcribed sequence at the DNF15S2 locus at chromosome 3P21.
    Harbour JW; Lai SL; Gazdar AF; Minna JD; Kaye FJ
    Anticancer Res; 1990; 10(1):23-7. PubMed ID: 2159253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant hypermethylation at the bcl-2 locus at 18q21 in human lung cancers.
    Nagatake M; Osada H; Kondo M; Uchida K; Nishio M; Shimokata K; Takahashi T; Takahashi T
    Cancer Res; 1996 Apr; 56(8):1886-91. PubMed ID: 8620509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BAG-1 haplo-insufficiency impairs lung tumorigenesis.
    Götz R; Kramer BW; Camarero G; Rapp UR
    BMC Cancer; 2004 Nov; 4():85. PubMed ID: 15560850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.
    Girard L; Zöchbauer-Müller S; Virmani AK; Gazdar AF; Minna JD
    Cancer Res; 2000 Sep; 60(17):4894-906. PubMed ID: 10987304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of loss of heterozygosity in large cell neuroendocrine carcinomas of the lung and small cell lung carcinomas.
    Takeuchi T; Minami Y; Iijima T; Kameya T; Asamura H; Noguchi M
    Pathol Int; 2006 Aug; 56(8):434-9. PubMed ID: 16872437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.